True Leaf Announces Initial Closing of its Regulation A+ Offering
January 12 2018 - 4:15PM
True Leaf Medicine International Ltd. (“
True Leaf”
or the “
Company”) (CSE:MJ) (FSE:TLA)
(OTCQB:TRLFF), announces that it has conducted an initial closing
of its previously announced Regulation A+ offering for gross
proceeds in the amount of C$6.18 million for 8,883,590 shares.
True Leaf’s Regulation A+ offering was qualified
by the Securities and Exchange Commission (SEC) on November 21,
2017, and allows the Company to sell up to 14,285,715 common shares
at an offering price of $0.70 CAD per share in the United
States.
Boustead Securities, LLC, working with its
affiliate, FlashFunders™ (www.flashfunders.com), is the lead
managing selling agent and bookrunner for the offering. CrowdfundX
is the digital marketing agency of record.
About True Leaf
Founded in 2013, True Leaf has two main
operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc.
The Company’s goal is to provide federally-approved cannabis
products that will be sold across Canada and the United States.
True Leaf Medicine Inc. was launched in July 2013 to become a
licensed producer of medicinal cannabis for the Canadian market.
True Leaf Medicine Inc. has been given approval by Health Canada to
build its grow facility and will be subject to a Health Canada
security inspection upon completion to allow for the cultivation,
manufacture, and distribution of cannabis products. Currently, True
Leaf does not have a license to produce cannabis.
Established in 2015, True Leaf Pet Inc. markets
hemp-focused products for the pet industry. The Company launched
the True Hemp™ pet supplement line in Canada, the United States,
and Europe, becoming one of the first hemp-based pet product lines
to be marketed worldwide. True Hemp™ North American products are
free of CBD and THC, making them the first federally legal products
to be marketed in Canada and the United States.
SEC Legends
An offering statement regarding this offering
has been filed with the SEC. The SEC has qualified that offering
statement, which only means that we may make sales of the
securities described by the offering statement. It does not mean
that the SEC has approved, passed upon the merits, or passed upon
the accuracy or completeness of the information in the offering
statement. You may obtain a copy of the offering circular that is
part of that offering statement from: HERE
Forward-Looking Statements
This news release contains forward-looking
statements; and management may make additional forward-looking
statements in response to your questions. Such written and oral
disclosures are made pursuant to the Safe Harbor provision of the
Private Securities Litigation Reform Act of 1995. Although we
believe our expectations expressed in such forward-looking
statements are reasonable, we cannot assure you that they will be
realized. Investors are cautioned that such forward-looking
statements involve risks and uncertainties that could cause actual
results to differ materially from the anticipated results, and
therefore we refer you to a more detailed discussion of the risks
and uncertainties in the Company’s filings with the Securities and
Exchange Commission when available. The forward-looking statements
contained in this news release are made only as of today; and True
Leaf Medicine International Ltd. is under no obligation to revise
or update these forward-looking statements.
Media
Contact:
Paul
Sullivan
Director, Public RelationsPaul@trueleaf.comO: 604-685-4742M:
604-603-7358
Investor Contact:
Kevin Bottomley (Canada) Director and Corporate
RelationsKevin@trueleaf.com M: 778-389-9933
Tirth Patel (US)Edison
Advisorstpatel@edisongroup.com O: 646-653-7035
Follow True Leaf
trueleaf.com
twitter.com/trueleafpet
facebook.com/trueleafmedicine
instagram.com/trueleafpet
True Leaf Brands (CSE:MJ)
Historical Stock Chart
From Nov 2024 to Dec 2024
True Leaf Brands (CSE:MJ)
Historical Stock Chart
From Dec 2023 to Dec 2024